Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Analysis of diabetes-associated autoantibodies in children and adolescents with autoimmune thyroid diseases.

Rydzewska M, Michalak J, Bossowska A, Chen S, Black S, Powell M, Furmaniak J, Rees Smith B, Bossowski A.

J Pediatr Endocrinol Metab. 2019 Apr 24;32(4):355-361. doi: 10.1515/jpem-2018-0367.

PMID:
30903759
2.

Crystal Structure of a Ligand-free Stable TSH Receptor Leucine-Rich Repeat Domain.

Miller-Gallacher J, Sanders P, Young S, Sullivan A, Baker S, Reddington SC, Clue M, Kabelis K, Clark J, Wilmot J, Thomas D, Chlebowska M, Cole F, Pearson E, Roberts E, Holly M, Evans M, Núñez Miguel R, Powell M, Sanders J, Furmaniak J, Rees Smith B.

J Mol Endocrinol. 2019 Jan 1. pii: JME-18-0213.R2. doi: 10.1530/JME-18-0213. [Epub ahead of print]

PMID:
30689545
3.

THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS.

Naletto L, Frigo A, Ceccato F, Sabbadin C, Scarpa R, Presotto F, Dalla Costa M, Faggian D, Plebani M, Censi S, Manso J, Furmaniak J, Chen S, Rees Smith B, Masiero S, Pigliaru F, Boscaro M, Scaroni C, Betterle C.

Eur J Endocrinol. 2019 Jan 1. pii: EJE-18-0313.R3. doi: 10.1530/EJE-18-0313. [Epub ahead of print]

PMID:
30608902
4.

Thyrotrophin receptor antibody concentration and activity, several years after treatment for Graves' disease.

Nalla P, Young S, Sanders J, Carter J, Adlan MA, Kabelis K, Chen S, Furmaniak J, Rees Smith B, Premawardhana LDKE.

Clin Endocrinol (Oxf). 2019 Feb;90(2):369-374. doi: 10.1111/cen.13908. Epub 2018 Dec 17.

PMID:
30485487
5.

A new ELISA for autoantibodies to steroid 21-hydroxylase.

Del Pilar Larosa M, Chen S, Steinmaus N, Macrae H, Guo L, Masiero S, Garelli S, Costa MD, Bossowski A, Furmaniak J, Betterle C, Smith BR.

Clin Chem Lab Med. 2018 May 24;56(6):933-938. doi: 10.1515/cclm-2017-0456.

PMID:
29267164
6.

Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.

Larosa MDP, Mackenzie R, Burne P, Garelli S, Barollo S, Masiero S, Rubin B, Chen S, Furmaniak J, Betterle C, Smith BR.

Clin Chem Lab Med. 2017 Jun 27;55(7):1003-1012. doi: 10.1515/cclm-2016-0615.

PMID:
28099118
7.

Structure and activation of the TSH receptor transmembrane domain.

Núñez Miguel R, Sanders J, Furmaniak J, Smith BR.

Auto Immun Highlights. 2017 Dec;8(1):2. doi: 10.1007/s13317-016-0090-1. Epub 2016 Dec 5.

8.

Glycosylation pattern analysis of glycoprotein hormones and their receptors.

Núñez Miguel R, Sanders J, Furmaniak J, Rees Smith B.

J Mol Endocrinol. 2017 Jan;58(1):25-41. Epub 2016 Nov 14.

PMID:
27875255
9.

3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD65, to IA-2 and to ZnT8.

Amoroso M, Achenbach P, Powell M, Coles R, Chlebowska M, Carr L, Furmaniak J, Scholz M, Bonifacio E, Ziegler AG, Rees Smith B.

Clin Chim Acta. 2016 Nov 1;462:60-64. doi: 10.1016/j.cca.2016.08.013. Epub 2016 Aug 26.

PMID:
27570064
10.

3 Screen ELISA for High-Throughput Detection of Beta Cell Autoantibodies in Capillary Blood.

Ziegler AG, Haupt F, Scholz M, Weininger K, Wittich S, Löbner S, Matzke C, Gezginci C, Riethausen S, Beyerlein A, Zillmer S, Amoroso M, Coles R, Powell M, Furmaniak J, Smith BR, Winkler C, Bonifacio E, Achenbach P.

Diabetes Technol Ther. 2016 Nov;18(11):687-693. Epub 2016 Aug 23.

PMID:
27552135
11.

Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes.

Głowińska-Olszewska B, Michalak J, Łuczyński W, Del Pilar Larosa M, Chen S, Furmaniak J, Smith BR, Bossowski A.

J Pediatr Endocrinol Metab. 2016 Jun 1;29(6):647-56. doi: 10.1515/jpem-2015-0190.

PMID:
27008690
12.

Relationships between major epitopes of the IA-2 autoantigen in Type 1 diabetes: Implications for determinant spreading.

McLaughlin KA, Richardson CC, Williams S, Bonifacio E, Morgan D, Feltbower RG, Powell M, Rees Smith B, Furmaniak J, Christie MR.

Clin Immunol. 2015 Oct;160(2):226-36. doi: 10.1016/j.clim.2015.06.002. Epub 2015 Jun 9.

13.

Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.

Dunseath G, Ananieva-Jordanova R, Coles R, Powell M, Amoroso M, Furmaniak J, Smith BR, Dayan C, Luzio S.

Clin Chim Acta. 2015 Jul 20;447:90-5. doi: 10.1016/j.cca.2015.05.010. Epub 2015 May 22.

PMID:
26006309
14.

GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.

Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P.

Diabetes Care. 2014 Jun;37(6):1675-80. doi: 10.2337/dc13-1719. Epub 2014 Mar 5.

PMID:
24598244
15.

Addison's disease: a survey on 633 patients in Padova.

Betterle C, Scarpa R, Garelli S, Morlin L, Lazzarotto F, Presotto F, Coco G, Masiero S, Parolo A, Albergoni MP, Favero R, Barollo S, Salvà M, Basso D, Chen S, Rees Smith B, Furmaniak J, Mantero F.

Eur J Endocrinol. 2013 Oct 21;169(6):773-84. doi: 10.1530/EJE-13-0528. Print 2013 Dec.

PMID:
24014553
16.

Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes.

Richardson CC, McLaughlin KA, Brown TJ, Morgan D, Feltbower R, Powell M, Furmaniak J, Rees Smith B, Christie MR.

Autoimmunity. 2013 Sep;46(6):375-81. doi: 10.3109/08916934.2013.773978.

PMID:
24001205
17.

Blocking type TSH receptor antibodies.

Furmaniak J, Sanders J, Rees Smith B.

Auto Immun Highlights. 2012 Mar 21;4(1):11-26. doi: 10.1007/s13317-012-0028-1. eCollection 2013 Apr. Review.

18.

Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica.

Isobe N, Yonekawa T, Matsushita T, Masaki K, Yoshimura S, Fichna J, Chen S, Furmaniak J, Smith BR, Kira J.

Neurochem Res. 2013 May;38(5):997-1001. doi: 10.1007/s11064-013-1009-0. Epub 2013 Mar 2.

PMID:
23456674
19.

IA-2 autoantibody affinity in children at risk for type 1 diabetes.

Krause S, Chmiel R, Bonifacio E, Scholz M, Powell M, Furmaniak J, Rees Smith B, Ziegler AG, Achenbach P.

Clin Immunol. 2012 Dec;145(3):224-9. doi: 10.1016/j.clim.2012.09.010. Epub 2012 Oct 3.

PMID:
23110943
20.

Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.

Núñez Miguel R, Sanders J, Sanders P, Young S, Clark J, Kabelis K, Wilmot J, Evans M, Roberts E, Hu X, Furmaniak J, Rees Smith B.

J Mol Endocrinol. 2012 Aug 30;49(2):137-51. doi: 10.1530/JME-12-0040. Print 2012 Oct.

PMID:
22829655
21.

Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease.

Pearce SH, Mitchell AL, Bennett S, King P, Chandran S, Nag S, Chen S, Smith BR, Isaacs JD, Vaidya B.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1927-32. doi: 10.1210/jc.2012-1680. Epub 2012 Jul 5.

22.

Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.

Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, Yoshimura S, Fichna J, Chen S, Furmaniak J, Smith BR, Kira J.

Mult Scler. 2012 Nov;18(11):1541-51. doi: 10.1177/1352458512443917. Epub 2012 Apr 23.

PMID:
22526930
23.

In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70).

Furmaniak J, Sanders J, Young S, Kabelis K, Sanders P, Evans M, Clark J, Wilmot J, Rees Smith B.

Auto Immun Highlights. 2011 Sep 14;3(1):19-25. doi: 10.1007/s13317-011-0025-9. eCollection 2012 Apr.

24.

Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.

Falorni A, Chen S, Zanchetta R, Yu L, Tiberti C, Bacosi ML, Furmaniak J, Bini V, Dotta F, Eisenbarth GS, Smith BR, Betterle C.

Clin Immunol. 2011 Sep;140(3):291-9. doi: 10.1016/j.clim.2011.04.012. Epub 2011 Apr 28.

PMID:
21570358
25.

Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.

Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, Evans M, Clark J, Wilmot J, Hu X, Roberts E, Powell M, Núñez Miguel R, Furmaniak J, Rees Smith B.

J Mol Endocrinol. 2011 Feb 15;46(2):81-99. doi: 10.1530/JME-10-0127. Print 2011 Apr.

PMID:
21247981
26.

TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.

Sanders J, Miguel RN, Furmaniak J, Smith BR.

Methods Enzymol. 2010;485:393-420. doi: 10.1016/B978-0-12-381296-4.00022-1.

PMID:
21050929
27.

AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED.

Cervato S, Morlin L, Albergoni MP, Masiero S, Greggio N, Meossi C, Chen S, del Pilar Larosa M, Furmaniak J, Rees Smith B, Alimohammadi M, Kämpe O, Valenzise M, Betterle C.

Clin Endocrinol (Oxf). 2010 Nov;73(5):630-6. doi: 10.1111/j.1365-2265.2010.03862.x.

PMID:
20718774
28.

Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample.

Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, Wilmot J, Hu X, Kabelis K, Clark J, Holl S, Richards T, Collyer A, Furmaniak J, Smith BR.

Clin Endocrinol (Oxf). 2010 Sep;73(3):404-12. doi: 10.1111/j.1365-2265.2010.03831.x. Epub 2010 Jun 9.

PMID:
20550534
29.

Thyrotropin receptor structure--in the crystal new horizons shine.

Furmaniak J, Sanders J, Smith BR.

Endocr Pract. 2009 Jan-Feb;15(1):56-60. No abstract available.

PMID:
19211401
30.

Implications of new monoclonal antibodies and the crystal structure of the TSH receptor for the treatment and management of thyroid diseases.

Rees Smith B, Sanders J, Furmaniak J.

Biomark Med. 2008 Dec;2(6):567-76. doi: 10.2217/17520363.2.6.567.

PMID:
20477447
31.

TSH receptor blocking antibodies.

Smith BR, Furmaniak J, Sanders J.

Thyroid. 2008 Nov;18(11):1239. No abstract available.

PMID:
19031548
32.

The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.

Ochi Y, Hamazu M, Kajita Y, Hachiya T, Miyata T, Barrett C, Smith BR.

Thyroid. 2009 Jan;19(1):47-52. doi: 10.1089/thy.2007.0351.

PMID:
18976151
33.

A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.

Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A, Small K, Platt H, Summerhayes S, Harris R, Reeve M, Coco G, Zanchetta R, Chen S, Furmaniak J, Smith BR.

Thyroid. 2008 Jul;18(7):735-46. doi: 10.1089/thy.2007.0327.

PMID:
18631002
34.

Analysis of the GAD65-GAD65 autoantibody interaction.

Coco G, Chen S, Powell M, Brooking H, Zanchetta R, Betterle C, Smith BR, Furmaniak J.

Clin Chim Acta. 2008 May;391(1-2):51-9. doi: 10.1016/j.cca.2008.02.005. Epub 2008 Feb 14.

PMID:
18328264
35.

Calcium addition to EDTA plasma eliminates falsely positive results in the RSR GADAb ELISA.

Nilson E, Ekholm B, Rees Smith B, Törn C, Hillman M.

Clin Chim Acta. 2008 Feb;388(1-2):130-4. Epub 2007 Nov 1.

PMID:
18023278
36.

TSH receptor antibodies.

Smith BR, Sanders J, Furmaniak J.

Thyroid. 2007 Oct;17(10):923-38. Review.

PMID:
17900238
37.

Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.

Sanders J, Miguel RN, Bolton J, Bhardwaja A, Sanders P, Nakatake N, Evans M, Furmaniak J, Smith BR.

Thyroid. 2007 Aug;17(8):699-706.

PMID:
17725428
38.

Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.

Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR.

Thyroid. 2007 May;17(5):395-410.

PMID:
17542669
39.

Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.

Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, Evans M, Kiddie A, Summerhayes S, Roberts E, Miguel RN, Furmaniak J, Smith BR.

Thyroid. 2006 Dec;16(12):1195-206. Erratum in: Thyroid. 2007 Feb;17(2):188.

PMID:
17199429
40.

Estimation of serum TSH receptor autoantibody concentration and affinity.

Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Pra CD, Presotto F, Betterle C, Furmaniak J, Smith BR.

Thyroid. 2006 Nov;16(11):1077-84.

PMID:
17123333
41.

Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.

Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C.

J Clin Endocrinol Metab. 2006 May;91(5):1637-45. Epub 2006 Mar 7.

PMID:
16522688
42.

Analysis of the interaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling.

Miguel RN, Chen S, Nikfarjam L, Kominami S, Carpenter B, Dal Pra C, Betterle C, Zanchetta R, Nakamatsu T, Powell M, Hewer R, Blundell TL, Smith BR, Furmaniak J.

Eur J Endocrinol. 2005 Dec;153(6):949-61.

PMID:
16322402
43.

Point-of-care assays for autoantibodies to thyroid peroxidase and to thyroglobulin.

Burne P, Mitchell S, Rees Smith B.

Thyroid. 2005 Sep;15(9):1005-10.

PMID:
16187908
44.

Comparative modeling of the thyrotropin receptor.

Miguel RN, Sanders J, Blundell TL, Smith BR, Furmaniak J.

Thyroid. 2005 Jul;15(7):746-7. No abstract available.

PMID:
16178067
45.

A mouse monoclonal antibody to the TSHR.

Stankowiak-Kulpa H, Sanders J, Depraetere H, Jeffreys J, Evans M, Richards T, Furmaniak J, Smith BR.

Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):345-51.

PMID:
16088319
46.

A sensitive non-isotopic assay for acetylcholine receptor autoantibodies.

Hewer R, Matthews I, Chen S, McGrath V, Evans M, Roberts E, Nute S, Sanders J, Furmaniak J, Smith BR.

Clin Chim Acta. 2006 Feb;364(1-2):159-66. Epub 2005 Jul 27.

PMID:
16051208
47.

Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.

Chen S, Willis J, Maclean C, Ananieva-Jordanova R, Amoroso MA, Brooking H, Powell M, Collins A, Bennett S, Mitchell S, Burne P, Furmaniak J, Smith BR.

Clin Chim Acta. 2005 Jul 1;357(1):74-83. Epub 2005 Apr 7.

PMID:
15963796
48.

Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling.

Núñez Miguel R, Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Blundell TL, Rees Smith B, Furmaniak J.

Thyroid. 2004 Dec;14(12):991-1011.

PMID:
15650352
49.

A new assay for thyrotropin receptor autoantibodies.

Smith BR, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, Weightman D, Perros P, Sanders J, Furmaniak J.

Thyroid. 2004 Oct;14(10):830-5.

PMID:
15588379
50.

Muscle-specific receptor tyrosine kinase autoantibodies--a new immunoprecipitation assay.

Matthews I, Chen S, Hewer R, McGrath V, Furmaniak J, Rees Smith B.

Clin Chim Acta. 2004 Oct;348(1-2):95-9.

PMID:
15369741

Supplemental Content

Loading ...
Support Center